Literature DB >> 18465683

Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index.

L Bajnok1, I Seres, Z Varga, S Jeges, A Peti, Z Karanyi, A Juhasz, E Csongradi, E Mezosi, E V Nagy, G Paragh.   

Abstract

UNLABELLED: The relationship between resistin, one of the adipokines, and metabolic syndrome is not fully elucidated. Altered activity of the HDL-associated antioxidant enzyme paraoxonase 1 (PON1) that participates in the antioxidant defense mechanisms of HDL may have an important role in the obesity-related accelerated atherosclerosis. Inverse associations of PON1 with obesity and serum levels of leptin have been demonstrated. Our aim was to investigate the association of serum levels of resistin with (i) PON1 activity, and (ii) parameters of metabolic syndrome, including some that are additional for research. A total of 74 Caucasian subjects were recruited into the study and divided into 3 age and sex-matched groups. Group 1, 25 non-diabetic overweight/obese subjects with BMI of 28-39.9 kg/m (2); group 2, 25 non-diabetic obese patients with BMI >or=40 kg/m (2); and the control group 3, 24 healthy, normal-weight control subjects. Serum levels of resistin were correlated negatively with BMI (r=-0.27, P<0.05), waist circumference (r=-0.28, P<0.05), serum levels of leptin (r=-0.28, P<0.05), non-esterified fatty acids (NEFA) (r=-0.23, P<0.05), and HbA (1C) (r=-0.26, P<0.05), systolic BP (r=-0.28, P<0.05), and lipid peroxidation (measured by TBARS) (r=-0.40, P<0.01), and correlated positively with PON1 (r=0.24, P<0.05). No association was detected between the serum concentrations of resistin and the following investigated parameters: diastolic BP, levels of uric acid, glucose, insulin, or insulin resistance (measured by homeostasis model assessment, HOMA-IR), triglyceride, total cholesterol, LDL-C, and HDL-C. During multiple regression analyses BMI and TBARS were independent predictors of PON1, while age, gender, blood pressure, HOMA-IR, LDL-C, HDL-C, and resistin were not.
CONCLUSIONS: Among the study subjects, serum levels of resistin showed a positive, although not independent correlation with serum PON1, and a negative correlation with numerous parameters of the metabolic syndrome (i.e. adiposity, blood pressure, levels of leptin, free fatty acid, glycosylated hemoglobin, and lipid peroxidation). BMI and TBARS are independent predictors of PON1 activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18465683     DOI: 10.1055/s-2008-1065350

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  8 in total

1.  Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women.

Authors:  Beom-Jun Kim; Shin-Yoon Kim; Yoon Shin Cho; Bon-Jo Kim; Bok-Ghee Han; Eui-Kyun Park; Seung Hun Lee; Ha Young Kim; Ghi Su Kim; Jong-Young Lee; Jung-Min Koh
Journal:  Exp Mol Med       Date:  2011-02-28       Impact factor: 8.718

2.  Indices of paraoxonase and oxidative status do not enhance the prediction of subclinical cardiovascular disease in mixed-ancestry South Africans.

Authors:  M Macharia; A P Kengne; D M Blackhurst; R T Erasmus; M Hoffmann; T E Matsha
Journal:  Oxid Med Cell Longev       Date:  2014-03-27       Impact factor: 6.543

3.  Physical activity increases the resistin concentration in hemodialyzed patients without metabolic syndrome.

Authors:  Beata Hornik; Jan Duława; Jan Szewieczek; Jacek Durmała
Journal:  Diabetes Metab Syndr Obes       Date:  2018-12-18       Impact factor: 3.168

Review 4.  Paraoxonase-1 as a Regulator of Glucose and Lipid Homeostasis: Impact on the Onset and Progression of Metabolic Disorders.

Authors:  Maria João Meneses; Regina Silvestre; Inês Sousa-Lima; Maria Paula Macedo
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

5.  Crosstalk Between Adipokines and Paraoxonase 1: A New Potential Axis Linking Oxidative Stress and Inflammation.

Authors:  Veronica Tisato; Arianna Romani; Elisa Tavanti; Elisabetta Melloni; Daniela Milani; Gloria Bonaccorsi; Juana M Sanz; Donato Gemmati; Angelina Passaro; Carlo Cervellati
Journal:  Antioxidants (Basel)       Date:  2019-08-06

6.  Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia.

Authors:  Sunil K Kota; Lalit K Meher; Siva K Kota; Sruti Jammula; S V S Krishna; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2013-05

7.  Serum paraoxonase/arylesterase activity and oxidative stress status in children with metabolic syndrome.

Authors:  Erdal Eren; Mahmut Abuhandan; Abdullah Solmaz; Abdullah Taşkın
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-09

8.  Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.

Authors:  Péter Fülöp; Ildikó Seres; Hajnalka Lőrincz; Mariann Harangi; Sándor Somodi; György Paragh
Journal:  J Cell Mol Med       Date:  2014-04-06       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.